Overview
The main objective is to describe the evolution of patients treated for a primary malignant hepatobiliary tumor (hepatocellular carcinoma or cholangiocarcinoma) over the long course.
Description
The collection of data from patients with CHC and cholangiocarcinomas who are cancers with poor prognosis is a major challenge to improve patients'care (diagnosis, prognosis); facilitate the search for new therapeutic targets and the follow-up of clinical studies; and develop personalized treatments.
Eligibility
Inclusion Criteria:
Inclusion Criteria :
- Age ≥ 18 years olds
- Medical care in Nephrology department since 2015
- Cholangiocarcinoma
-
- Histologically and cytologically documented cholangiocarcinoma, regardless of the stage of the disease
Hepatocellular carcinoma:
- Hepatocellular carcinoma at any stage of the disease, presenting the diagnostic criteria according to the diagnostic criteria of Barcelona : Tumor of more than 1 cm, developed on cirrhosis liver with arterial phase hyperenhancement and washout in the portal venous or delayed phases on CT and MRI
- Hepatocellular histologically documented
Exclusion Criteria:
- Lack of patient non-opposition